CoChat

The p53-family members p63 and p73 inhibit insulin-like growth factor-I receptor gene expression in colon cancer cells

Nahor, Irit, Abramovitch, Shirley, Engeland, Kurt, Werner, Haim · 2005 · Growth Hormone & IGF Research
Cited by 42

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ghir.2005.07.005

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 47

  1. LeRoith, 1995, Molecular and cellular aspects of the insulin-like growth factor I receptor, Endocr. Rev., 16, 143, 10.1210/edrv-16-2-143 · DOI · Paper page
  2. Bondy, 1990, Cellular pattern of insulin-like growth factor I and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression, Mol. Endocrinol., 4, 1386, 10.1210/mend-4-9-1386 · DOI · Paper page
  3. Werner, 1989, Developmental regulation of the rat insulin-like growth factor I receptor gene, Proc. Natl. Acad. Sci. USA, 86, 7451, 10.1073/pnas.86.19.7451 · DOI · Paper page
  4. Mitsiades, 2004, Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors, Cancer Cell, 5, 221, 10.1016/S1535-6108(04)00050-9 · DOI · Paper page
  5. Kiess, 1998, Hormonal control of programmed cell death/apoptosis, Eur. J. Endocrinol., 138, 482, 10.1530/eje.0.1380482 · DOI
  6. Werner, 2003, The IGF-I receptor gene: a molecular target for disrupted transcription factors, Gene. Chromosome. Cancer, 36, 113, 10.1002/gcc.10157 · DOI
  7. Werner, 1990, Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor I receptor gene, Biochem. Biophys. Res. Commun., 169, 1021, 10.1016/0006-291X(90)91996-6 · DOI
  8. Werner, 1992, Structural and functional analysis of the insulin-like growth factor I receptor gene promoter, Mol. Endocrinol., 6, 1545
  9. Cooke, 1991, Analysis of the human type I insulin-like growth factor receptor promoter region, Biochem. Biophys. Res. Commun., 177, 1113, 10.1016/0006-291X(91)90654-P · doi:10.1016/0006-291x(91)90654-p
  10. Werner, 1993, Increased expression of the insulin-like growth factor-I receptor gene, IGFIR, in Wilms’ tumor is correlated with modulation of IGFIR promoter activity by the WT1 Wilms’ tumor gene product, Proc. Natl. Acad. Sci. USA, 90, 5828, 10.1073/pnas.90.12.5828 · doi:10.1073/pnas.90.12.5828
  11. Rubinstein, 2004, Transcriptional activation of the IGF-I receptor gene by the Kruppel-like factor-6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53, Endocrinology, 145, 3769, 10.1210/en.2004-0173 · DOI · Paper page
  12. Abramovitch, 2003, BRCA1-Sp1 interactions in transcriptional regulation of the IGF-IR gene, FEBS Lett., 541, 149, 10.1016/S0014-5793(03)00315-6 · DOI
  13. Werner, 1996, Wild type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene, Proc. Natl. Acad. Sci. USA, 93, 8318, 10.1073/pnas.93.16.8318 · DOI · Paper page
  14. Ohlsson, 1998, p53 regulates IGF-I receptor expression and IGF-I induced tyrosine phosphorylation in an osteosarcoma cell line: Interaction between p53 and Sp1, Endocrinology, 139, 1101, 10.1210/endo.139.3.5832 · doi:10.1210/endo.139.3.5832 · Paper page
  15. Girnita, 2000, Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: functional impact, Cancer Res., 60, 5278
  16. Prisco, 1997, The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal, Mol. Cell. Biol., 17, 1084, 10.1128/MCB.17.3.1084 · DOI · Paper page
  17. Irwin, 2001, p53 family update: p73 and p63 develop their own identities, Cell Growth Diff., 12, 337
  18. Yang, 2000, p63 and p73: p53 mimics, menaces and more, Nat. Rev., 1, 199, 10.1038/35043127 · DOI · Paper page
  19. Yang, 1998, p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities, Mol. Cell, 2, 305, 10.1016/S1097-2765(00)80275-0 · DOI · Paper page
  20. Kaghad, 1997, Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers, Cell, 90, 809, 10.1016/S0092-8674(00)80540-1 · DOI · Paper page
  21. Schmale, 1997, A novel protein with strong homology to the tumor suppressor p53, Oncogene, 15, 1363, 10.1038/sj.onc.1201500 · DOI · Paper page
  22. Dietz, 2002, Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73, FEBS Lett., 525, 93, 10.1016/S0014-5793(02)03093-4 · DOI
  23. Deb, 2001, Differential modulation of cellular and viral promoters by p73 and p53, Int. J. Oncol., 18, 401
  24. Sekharam, 2003, Insulin-like growth factor-I receptor enhances invasion and reduces resistance to apoptosis of colon cancer cells through the Akt/Bcl-x(L) pathway, Cancer Res., 63, 7708
  25. Ma, 1999, Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor-I and IGF-binding protein-3, J. Natl. Cancer Inst., 91, 620, 10.1093/jnci/91.7.620 · DOI · Paper page
  26. Sun, 2002, p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma, Clin. Cancer Res., 8, 165
  27. Tannapfel, 1999, Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma, J. Natl. Cancer Inst., 91, 1154, 10.1093/jnci/91.13.1154 · DOI · Paper page
  28. Stiewe, 2002, Role of p73 in malignancy: tumor suppressor or oncogene, Cell Death Diff., 9, 237, 10.1038/sj.cdd.4400995 · DOI
  29. Sasaki, 2001, Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: potential application to gene therapy of colorectal cancer, Gene Ther., 8, 1401, 10.1038/sj.gt.3301538 · DOI
  30. Bunz, 1998, Requirement for p53 and p21 to sustain G2 arrest after DNA damage, Science, 282, 1497, 10.1126/science.282.5393.1497 · DOI · Paper page
  31. Chakrabarty, 1992, Modulation of differentiation-related responses in human colon carcinoma cells by protein kinase inhibitor H-7, Anticancer Res., 12, 97
  32. Werner, 1994, Transcriptional repression of the insulin-like growth factor I receptor gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site, J. Biol. Chem., 269, 12577, 10.1016/S0021-9258(18)99914-X · doi:10.1016/s0021-9258(18)99914-x
  33. Brasier, 1989, Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines, Biotechniques, 7, 1116
  34. Benard, 2003, TP53 family members and human cancer, Hum. Mutat., 21, 182, 10.1002/humu.10172 · DOI · Paper page
  35. Strano, 2002, Physical interaction with human tumor-derived p53 mutants inhibits p63 activities, J. Biol. Chem., 277, 18817, 10.1074/jbc.M201405200 · DOI · Paper page
  36. Beitner-Johnson, 1995, Regulation of insulin-like growth factor I receptor gene expression by Sp1: physical and functional interactions of Sp1 at GC boxes and at a CT element, Mol. Endocrinol., 9, 1147
  37. Wu, 2002, Circulating IGF-I levels regulate colon cancer growth and metastasis, Cancer Res., 62, 1030
  38. Grob, 2002, The two faces of p73, Cell Death Diff., 9, 237, 10.1038/sj.cdd.4401018 · DOI
  39. Blandino, 2004, p73 and p63: why do we still need them?, Cell Cycle, 3, 886, 10.4161/cc.3.7.996 · DOI
  40. Crook, 2000, High level expression of Del-N-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC), Oncogene, 19, 3439, 10.1038/sj.onc.1203656 · DOI · Paper page
  41. Spiesbach, 2004, TAp63 gamma can substitute for p53 in inducing expression of the maspin tumor suppressor, Int. J. Cancer, 114, 555, 10.1002/ijc.20766 · DOI
  42. Krause, 2000, The tumour suppressor protein p53 can repress transcription of cyclin B, Nucleic Acids Res., 28, 4410, 10.1093/nar/28.22.4410 · DOI · Paper page
  43. Nishi, 2001, p53 homologue p63 represses epidermal growth factor receptor expression, J. Biol. Chem., 276, 41717, 10.1074/jbc.M101241200 · DOI
  44. Yoon, 2004, Requirement of Kruppel-like factor 4 in preventing entry into mitosis following DNA damage, J. Biol. Chem., 279, 5035, 10.1074/jbc.M307631200 · DOI
  45. Zhu, 1998, The potential tumor suppressor p73 differentially regulates cellular p53 target genes, Cancer Res., 58, 5061
  46. Salimath, 2000, Expression of the vascular endothelial growth factor gene is inhibited by p73, Oncogene, 19, 3470, 10.1038/sj.onc.1203672 · DOI
  47. Bellamy, 1999, Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies, Cancer Res., 59, 728

Cited by

See all 42

Metadata

Authors
Nahor, I., Abramovitch, S., Engeland, K., & Werner, H.
Venue
Growth Hormone & IGF Research
Publisher
Elsevier BV
Published
2005-12
Volume
15
Issue
6
Pages
388-396
ISSN
1096-6374
Cited by
42
References
5
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The p53-family members p63 and p73 inhibit insulin-like growth factor-I receptor gene expression in colon cancer cells. https://app.cochat.ai/papers/10.1016/j.ghir.2005.07.005
The paper
Nahor, I., Abramovitch, S., Engeland, K., & Werner, H. (2005). The p53-family members p63 and p73 inhibit insulin-like growth factor-I receptor gene expression in colon cancer cells. Growth Hormone & IGF Research. https://doi.org/10.1016/j.ghir.2005.07.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.